Intra-Cellular Therapies | 10-Q: Q3 2024 Earnings Report
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS, PROVIDES CORPORATE UPDATE AND RAISES 2024 CAPLYTA SALES GUIDANCE
Intra-Cellular Therapies | 10-Q: Q2 2024 Earnings Report
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS, PROVIDES CORPORATE UPDATE AND RAISES 2024 CAPLYTA SALES GUIDANCE
Intra-Cellular Therapies | 10-Q: Q1 2024 Earnings Report
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Intra-Cellular Therapies | 10-K: FY2023 Annual Report
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND FULL-YEAR 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND RAISES 2023 CAPLYTA SALES GUIDANCE
Intra-Cellular Therapies | 10-Q: Q3 2023 Earnings Report
Intra-Cellular Therapies | 10-Q: Q2 2023 Earnings Report
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND RAISES 2023 CAPLYTA SALES GUIDANCE
Intra-Cellular Therapies | 10-Q: Q1 2023 Earnings Report
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Intra-Cellular Therapies | 10-K: FY2022 Annual Report
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Intra-Cellular Therapies | 10-Q: Q3 2022 Earnings Report
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Intra-Cellular Therapies | 10-Q: Q2 2022 Earnings Report
Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
No Data